Skip to main contentSkip to navigationSkip to search
HNSA (, %) SEK
Hansa Biopharma logotype

Farstorps Gård AB has divested Hansa Medical shares

Regulatory information
Hansa Medical has been informed that a small group of long-term institutional investors have acquired shares from Farstorps Gård AB

Following the divestiture, Farstorps Gård AB holds approximately 1 million shares in Hansa Medical, equivalent to approximately 3 percent of the number of outstanding shares in Hansa Medical. Farstorps Gård AB has informed Hansa Medical that Farstorps Gård AB will remain a long-term shareholder in the company and that Farstorps Gård has committed not to divest any further shares within the next 12 months (a so called 12 month lock-up period).

The information in this press release is disclosed pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was released for public disclosure on March 8, 2016 at 08.30 CET.